 |
|
New target for obesity and related metabolic disorders
March 08, 2006A new study reveals an attractive new target for therapies aimed at the treatment of obesity and related metabolic disorders, researchers report in the March Cell Metabolism. A novel compound, when delivered to rats on a high-fat diet, acted on the target receptor to suppress appetite and weight gain in the animals, they found.
As reported by Hilary Overton, Christine Reynet, and colleagues of the biotechnology company (OSI)Prosidion, the team found that so-called oleoylethanolamide, a naturally occurring lipid-signaling agent earlier shown to reduce food intake and weight gain in rats, can exert its effects through the G protein-coupled receptor (GPCR) GPR119. A large proportion of all drugs sold today target GPCRs, protein "switches" that recognize and translate signals into cellular responses. Found predominantly in the pancreas and digestive tract in humans and mice, as well as in the rodent brain, the function of GPR119 had previously remained mysterious.
After screening a proprietary library of small molecules including several hundred thousand compounds for their ability to activate GPR119, the researchers then identified one such chemical, known only as PSN632408. PSN632408 had no effect on the distantly related cannabinoid receptors, which are the targets of the candidate obesity drug rimonabant, the team reported.
PSN632408 led to a marked reduction in food intake in rats that took the compound orally, they reported. Total food intake over the first 24 hours was 10.4 percent lower in animals treated with 100 mg/kg PSN632408 than in control animals. Obese rats that were given PSN632408 everyday for two weeks also ate less and gained less weight and fat than those not taking the chemical.
"We think this might be quite a unique receptor for the treatment of obesity and other aspects of metabolic syndrome because of its localization in the gastrointestinal tract and its effect on fat mass," Reynet said. "We also have preliminary evidence for improvements on lipid profile and insulin sensitivity."
Further study found that PSN632408 and the prescribed weight-loss agent sibutramine similarly reduced food intake and weight gain in normal rats on a high-fat diet.
"Most of our studies suggest this prototypical compound might lead to reductions in body weight that can match the effects of sibutramine," added Jim McCormack, Vice President of Research for Prosidion Ltd. Sibutramine (Meridia®) is a marketed drug, although its use has been limited by its potential for side effects, including hypertension, McCormack noted. "While this is still the early days for understanding GPR119's function, the receptor offers potential for new agents for treating obesity and related metabolic disorders without the side effects."
Details of the mechanism by which such selective small molecules produce their effects remain to be elucidated, "but it is clear that this receptor system is a novel putative avenue for controlling caloric intake, body weight and some metabolic parameters, and hence has great potential value for discovering pharmaceuticals to alleviate the burdens of obesity and related metabolic disorders," the researchers said. The team said the search is on for additional compounds that might also act on GPR119.
Cell Press
PSN632408 led to a marked reduction in food intake in rats that took the compound orally, they reported. Total food intake over the first 24 hours was 10.4 percent lower in animals treated with 100 mg/kg PSN632408 than in control animals. Obese rats that were given PSN632408 everyday for two weeks also ate less and gained less weight and fat than those not taking the chemical.
"We think this might be quite a unique receptor for the treatment of obesity and other aspects of metabolic syndrome because of its localization in the gastrointestinal tract and its effect on fat mass," Reynet said. "We also have preliminary evidence for improvements on lipid profile and insulin sensitivity."
Further study found that PSN632408 and the prescribed weight-loss agent sibutramine similarly reduced food intake and weight gain in normal rats on a high-fat diet.
"Most of our studies suggest this prototypical compound might lead to reductions in body weight that can match the effects of sibutramine," added Jim McCormack, Vice President of Research for Prosidion Ltd. Sibutramine (Meridia®) is a marketed drug, although its use has been limited by its potential for side effects, including hypertension, McCormack noted. "While this is still the early days for understanding GPR119's function, the receptor offers potential for new agents for treating obesity and related metabolic disorders without the side effects."
Details of the mechanism by which such selective small molecules produce their effects remain to be elucidated, "but it is clear that this receptor system is a novel putative avenue for controlling caloric intake, body weight and some metabolic parameters, and hence has great potential value for discovering pharmaceuticals to alleviate the burdens of obesity and related metabolic disorders," the researchers said. The team said the search is on for additional compounds that might also act on GPR119.
Cell Press
Obesity Current Events and Obesity News RSSFat around the middle increases the risk of dementia
Women who store fat on their waist in middle age are more than twice as likely to develop dementia when they get older, reveals a new study from the Sahlgrenska Academy.
Other Illnesses, Body Weight Do Not Explain Racial Disparities in Colon Cancer Survival, UAB Researchers Say
A new study by University of Alabama at Birmingham (UAB) researchers shows that body-mass index (BMI) and co-existing medical conditions (co-morbidity) do not explain the decreased survival observed among African-Americans compared to Caucasians who also have colon cancer.
Diabetes surgery summit consensus lays foundation for new field of medicine
A first-of-its-kind consensus statement on diabetes surgery is published online today in the Annals of Surgery.
Daycare may double TV time for young children, study finds
In a new study, the amount of television viewed by many young children in child care settings doubles the previous estimates of early childhood screen time, with those in home-based settings watching significantly more on average than those in center-based daycares.
Patient's weight not linked to success of fibroid surgery
Obese patients are no more likely to have post-operative complications than those of average weight when undergoing robotic surgery to remove uterine fibroids, according to a study at Henry Ford Hospital.
Scripps research scientists find new link between insulin and core body temperature
A team led by scientists at The Scripps Research Institute have discovered a direct link between insulin-a hormone long associated with metabolism and metabolic disorders such as diabetes-and core body temperature.
Night Beat, Overtime and a Disrupted Sleep Pattern Can Harm Officers' Health
A police officer who works the night shift, typically from 8 p.m. to 4 a.m., already is at a disadvantage when it comes to getting a good "night's" sleep.
Fat collections linked to decreased heart function
Researchers from Boston University School of Medicine (BUSM) have shown that fat collection in different body locations, such as around the heart and the aorta and within the liver, are associated with certain decreased heart functions.
Teens' mental health affects how long they stay in school, new study shows
Queen's University researcher Steven Lehrer has won a prestigious international award in recognition of his contributions to health economics.
Playing sport up to the end of pregnancy is healthy for the baby and the mother
Contrary to more conservative customs, exercising up to the end of pregnancy has no harmful effect on the weight or size of the foetus.
More Obesity Current Events and Obesity News Articles
 |
Fat Politics: The Real Story behind America's Obesity Epidemic by J. Eric Oliver (Author) It seems almost daily we read newspaper articles and watch news reports exposing the growing epidemic of obesity in America. Our government tells us we are experiencing a major health crisis, with sixty percent of Americans classified as overweight, and one in four as obese. But how valid are these claims? In Fat Politics, J. Eric Oliver shows how a handful of doctors, government bureaucrats, and health researchers, with financial backing from the drug and weight-loss industries, have campaigned to create standards that mislead the public. They mislabel more than sixty million Americans as "overweight," inflate the health risks of being fat, and promote the idea that obesity is a killer disease. In reviewing the scientific evidence, Oliver shows there is little proof that obesity... |
 |
Fat - What No One Is Telling You Starring: Mary Dimino, Meredith Vieira, Brian Wansink, America Bracho, Rosie Dehli Directed By: Andrew Fredericks Also With: Mary Dimino (Writer), Deidre Sheehan (Producer), Felice Firestone (Producer), Jessica Bari (Producer), Linda Spain (Producer), Naomi S. Boak (Producer), Robert B. Sturm (Producer), Ted Hinck (Producer), Tom Keleher (Producer), Tom Spain (Producer), Tom Spain (Writer) |
 |
Handbook of Obesity Treatment by Thomas A. Wadden PhD (Editor), Albert J. Stunkard MD (Editor) The contemporary successor to the editors' earlier Obesity: Theory and Therapy, this comprehensive handbook guides mental health, medical, and allied health professionals through the process of planning and delivering individualized treatment services for those seeking help for obesity. Concise, extensively referenced chapters present foundational knowledge and review the full range of widely used interventions, including self-help, behavioral, and cognitive-behavioral approaches; pharmacotherapy; and surgery. Provided are state-of-the-art guidelines for assessing obese individuals for health risks and for mood and eating disorders; treatment algorithms for tailoring interventions to the severity of the client's problem; details on adjunctive interventions for improving body image and... |
 |
The Obesity Epidemic: Science, Morality and Ideology by Michael Gard (Author) The Obesity Epidemic adds a much-needed voice of skepticism to the increasingly alarmist debate about weight and health. Gard and Wright show that "obesity" is above all a deeply problematic cultural and political concept, making clear that the social meaning of fat is determined largely by moral and ideological agendas -- agendas that are all the more powerful because they cloak themselves in the mantle of objective science and public health. Indeed, this book demonstrates how and why concepts such as "science" and "health" are themselves far more problematic than those who invoke them like to admit. THE OBESITY EPIDEMIC is a superb contribution to the sociology of knowledge, and an essential text for anyone who wants to understand the current moral panic over fat. |
 |
Killer at Large Starring: Bill Clinton, Arnold Schwarzenegger, Michael Pollan, Mike Huckabee, Tom Harkin Directed By: Steven Greenstreet Obesity rates in the United States have skyrocketed over the last twenty years, with no end in sight provoking former Surgeon General, Richard Carmona to state that "obesity is a terror within. It is destroying our society from within and unless we do something about it, the magnitude of the dilemma will dwarf 9/11 or any other terrorist event that you can point out..." As this epidemic of obesity reaches out into even the most remote corners of the globe, only one thing seems clear, the issue is more complex than you could ever imagine. Seeking to trace the problem to it's root, we find ourselves in the African Savannah 4 million years ago where we discover how our hunter gatherer ancestry, when mixed in with our modern environment of convenience, stress and abundance has... |
 |
Cognitive-Behavioral Treatment of Obesity: A Clinician's Guide by Zafra Cooper DPhil DipPsych (Author), Dr. Christopher G. Fairburn DM FMedSci FRCPsych (Author), Deborah M. Hawker PhD DClinPsy (Author) The first cognitive-behavioral treatment manual for obesity, this volume presents an innovative therapeutic model currently being evaluated in controlled research at Oxford University. From leading clinical researchers, the approach is specifically designed to overcome a major weakness of existing therapies: posttreatment weight regain. The book details powerful ways to help patients not only to achieve weight loss, but also to modify the problematic cognitions that undermine long-term weight control. Drawing on strategies proven effective with such problems as binge eating, the manual contains everything needed to implement the treatment: intervention guidelines, case examples, and reproducible handouts and forms. |
 |
Eating Disorders and Obesity, Second Edition: A Comprehensive Handbook by Dr. Christopher G. Fairburn DM FMedSci FRCPsych (Editor), Kelly D. Brownell PhD (Editor) This unique handbook presents and integrates virtually all that is currently known about eating disorders and obesity in one authoritative, accessible, and eminently practical volume. From leading international authorities, 112 concise chapters encapsulate the latest information on all pertinent topics, from biological, psychological, and social processes associated with risk, to clinical methods for assessment and intervention. The contents are organized to highlight areas of overlap between lines of research that often remain disparate. Suggestions for further reading at the end of each chapter replace extended references and enhance the practical value and readability of the volume. |
 |
The Evolution of Obesity by Michael L. Power (Author), Jay Schulkin (Author) In this sweeping exploration of the relatively recent obesity epidemic, Michael L. Power and Jay Schulkin probe evolutionary biology, history, physiology, and medical science to uncover the causes of our growing girth. The unexpected answer? Our own evolutionary success. For most of the past few million years, our evolutionary ancestors' survival depended on being able to consume as much as possible when food was available and to store the excess energy for periods when it was scarce. In the developed world today, high-calorie foods are readily obtainable, yet the propensity to store fat is part of our species' heritage, leaving an increasing number of the world's people vulnerable to obesity. In an environment of abundant food, we are anatomically, physiologically,... |
 |
Overcoming Obesity (Home Use) Part of the award winning public television series Healthy Body/Healthy Mind. Approximately 127 million adults in the U.S. are overweight, 60 million obese, and 9 million severely obese. Obesity is a complex, multi-factorial chronic disease involving environmental (social and cultural), genetic, physiologic, metabolic, behavioral and psychological components. It is the second leading cause of preventable death in the U.S. In this episode we define people at risk and detail some of the Nutritional solutions to help people stay healthy. This product is manufactured on demand using DVD-R recordable media. Amazon.com's standard return policy will apply. |
 |
Handbook of Obesity: Clinical Applications, Third Edition by George A. Bray (Editor), Claude Bouchard (Editor) Handbook of Obesity: Clinical Applications, Third Edition is the premier reference for physicians and researchers in the field of obesity. Written by leading scientists and clinicians, this handbook offers unparalleled depth and breadth of coverage concerning this growing global and chronic disease that affects and exacerbates comorbid conditions including diabetes and heart disease. This Third Edition is full of many revisions including: The sections Etiology and Pathophysiology have been updated to reflect state-of-the-art advancements in the prevalence, etiology, and pathophysiology of obesity New chapters have been added and revisions made to the subjects of genetics, molecular biology, endocrine determinants of obesity, the metabolic... |
| © 2009 BrightSurf.com |